Erwan Bezard

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Living Beings

Macaca fascicularis

Anatomy

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Nadjar Agnès; Berton Olivier; Guo Shuhong; Leneuve Patricia; Dovero Sandra; Diguet Elsa; Tison François; Zhao Baolu; Holzenberger Martin; Bezard Erwan
IGF-1 signaling reduces neuro-inflammatory response and sensitivity of neurons to MPTP.
Barraud Quentin; Lambrecq Virginie; Forni Claude; McGuire Steve; Hill Michael; Bioulac Bernard; Balzamo Emmanuel; Bezard Erwan; Tison François; Ghorayeb Imad
Sleep disorders in Parkinson's disease: the contribution of the MPTP non-human primate model.
Reese René; Charron Giselle; Nadjar Agnès; Aubert Incarnation; Thiolat Marie-Laure; Hamann Melanie; Richter Angelika; Bezard Erwan; Meissner Wassilios G
High frequency stimulation of the entopeduncular nucleus sets the cortico-basal ganglia network to a new functional state in the dystonic hamster.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Erwan Bezard (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Nadjar Agnès; Berton Olivier; Guo Shuhong; Leneuve Patricia; Dovero Sandra; Diguet Elsa; Tison François; Zhao Baolu; Holzenberger Martin; Bezard Erwan
IGF-1 signaling reduces neuro-inflammatory response and sensitivity of neurons to MPTP.
Neurobiology of aging 2009;30(12):2021-30.
2009: Barraud Quentin; Lambrecq Virginie; Forni Claude; McGuire Steve; Hill Michael; Bioulac Bernard; Balzamo Emmanuel; Bezard Erwan; Tison François; Ghorayeb Imad
Sleep disorders in Parkinson's disease: the contribution of the MPTP non-human primate model.
Experimental neurology 2009;219(2):574-82.
2009: Reese René; Charron Giselle; Nadjar Agnès; Aubert Incarnation; Thiolat Marie-Laure; Hamann Melanie; Richter Angelika; Bezard Erwan; Meissner Wassilios G
High frequency stimulation of the entopeduncular nucleus sets the cortico-basal ganglia network to a new functional state in the dystonic hamster.
Neurobiology of disease 2009;35(3):399-405.
2009: Berton Olivier; Guigoni Céline; Li Qin; Bioulac Bernard H; Aubert Incarnation; Gross Christian E; Dileone Ralph J; Nestler Eric J; Bezard Erwan
Striatal overexpression of DeltaJunD resets L-DOPA-induced dyskinesia in a primate model of Parkinson disease.
Biological psychiatry 2009;66(6):554-61.
2009: Vital Anne; Fernagut Pierre-Olivier; Canron Marie-Hélène; Joux Julien; Bezard Erwan; Martin-Negrier Marie-Laure; Vital Claude; Tison François
The nigrostriatal pathway in Creutzfeldt-Jakob disease.
Journal of neuropathology and experimental neurology 2009;68(7):809-15.
2009: Berthet Amandine; Porras Grégory; Doudnikoff Evelyne; Stark Holger; Cador Martine; Bezard Erwan; Bloch Bertrand
Pharmacological analysis demonstrates dramatic alteration of D1 dopamine receptor neuronal distribution in the rat analog of L-DOPA-induced dyskinesia.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2009;29(15):4829-35.
2009: Schuster Stefan; Doudnikoff Evelyne; Rylander Daniella; Berthet Amandine; Aubert Incarnation; Ittrich Carina; Bloch Bertrand; Cenci M Angela; Surmeier D James; Hengerer Bastian; Bezard Erwan
Antagonizing L-type Ca2+ channel reduces development of abnormal involuntary movement in the rat model of L-3,4-dihydroxyphenylalanine-induced dyskinesia.
Biological psychiatry 2009;65(6):518-26.
2009: Nadjar Agnès; Gerfen Charles R; Bezard Erwan
Priming for l-dopa-induced dyskinesia in Parkinson's disease: a feature inherent to the treatment or the disease?
Progress in neurobiology 2009;87(1):1-9.
2008: Qin Chuan; Zhu Hua; Chen Yunxin; Li Jiamei; Deng Wei; Xu Yanfeng; Dai Xiaowei; Jia Chunshi; Kong Qi; Huang Lan; Liu Yali; Ma Chunmei; Xiao Chong; Liu Ying; Li Qin; Bezard Erwan
The vascular endothelial cell is a new origin of melanin pigment on cynomolgus macaque with neurocutaneous melanosis.
Pigment cell & melanoma research 2008;21(6):710-1.
2008: Nicholas Anthony P; Lubin Farah D; Hallett Penelope J; Vattem Padmapriya; Ravenscroft Paula; Bezard Erwan; Zhou Shaobo; Fox Susan H; Brotchie Jonathan M; Sweatt J David; Standaert David G
Striatal histone modifications in models of levodopa-induced dyskinesia.
Journal of neurochemistry 2008;106(1):486-94.
2008: Pioli E Y; Meissner W; Sohr R; Gross C E; Bezard E; Bioulac B H
Differential behavioral effects of partial bilateral lesions of ventral tegmental area or substantia nigra pars compacta in rats.
Neuroscience 2008;153(4):1213-24.
2008: Schuster Stefan; Nadjar Agnès; Guo Jun Tang; Li Qin; Ittrich Carina; Hengerer Bastian; Bezard Erwan
The 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor lovastatin reduces severity of L-DOPA-induced abnormal involuntary movements in experimental Parkinson's disease.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2008;28(17):4311-6.
2008: Bezard Erwan
[Striatal proteomic analysis suggests that first L-dopa dose equates to chronic exposure]
Médecine sciences : M/S 2008;24(4):368.
2008: Scheller Dieter; Stichel-Gunkel Christine; Lübbert Hermann; Porras Gregory; Ravenscroft Paula; Hill Michael; Bezard Erwan
Neuroprotective effects of rotigotine in the acute MPTP-lesioned mouse model of Parkinson's disease.
Neuroscience letters 2008;432(1):30-4.
2008: Reese Rene; Winter Christine; Nadjar Agnes; Harnack Daniel; Morgenstern Rudolf; Kupsch Andreas; Bezard Erwan; Meissner Wassilios
Subthalamic stimulation increases striatal tyrosine hydroxylase phosphorylation.
Neuroreport 2008;19(2):179-82.
2008: Porras Grégory; Bezard Erwan
Preclinical development of gene therapy for Parkinson's disease.
Experimental neurology 2008;209(1):72-81.
2008: Scholz Birger; Svensson Marcus; Alm Henrik; Sköld Karl; Fälth Maria; Kultima Kim; Guigoni Céline; Doudnikoff Evelyne; Li Qin; Crossman Alan R; Bezard Erwan; Andrén Per E
Striatal proteomic analysis suggests that first L-dopa dose equates to chronic exposure.
PloS one 2008;3(2):e1589.
2007: Gold Stephen J; Hoang Chau V; Potts Bryan W; Porras Gregory; Pioli Elsa; Kim Ki Woo; Nadjar Agnes; Qin Chuan; LaHoste Gerald J; Li Qin; Bioulac Bernard H; Waugh Jeffrey L; Gurevich Eugenia; Neve Rachael L; Bezard Erwan
RGS9-2 negatively modulates L-3,4-dihydroxyphenylalanine-induced dyskinesia in experimental Parkinson's disease.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2007;27(52):14338-48.
2007: Guo Shuhong; Yan Jingqi; Yang Tangbin; Yang Xianqiang; Bezard Erwan; Zhao Baolu
Protective effects of green tea polyphenols in the 6-OHDA rat model of Parkinson's disease through inhibition of ROS-NO pathway.
Biological psychiatry 2007;62(12):1353-62.
2007: Belujon Pauline; Bezard Erwan; Taupignon Anne; Bioulac Bernard; Benazzouz Abdelhamid
Noradrenergic modulation of subthalamic nucleus activity: behavioral and electrophysiological evidence in intact and 6-hydroxydopamine-lesioned rats.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2007;27(36):9595-606.
2007: Guigoni Céline; Doudnikoff Evelyne; Li Qin; Bloch Bertrand; Bezard Erwan
Altered D(1) dopamine receptor trafficking in parkinsonian and dyskinetic non-human primates.
Neurobiology of disease 2007;26(2):452-63.
2007: Aubert Incarnation; Guigoni Céline; Li Qin; Dovero Sandra; Bioulac Bernard H; Gross Christian E; Crossman Alan R; Bloch Bertrand; Bezard Erwan
Enhanced preproenkephalin-B-derived opioid transmission in striatum and subthalamic nucleus converges upon globus pallidus internalis in L-3,4-dihydroxyphenylalanine-induced dyskinesia.
Biological psychiatry 2007;61(7):836-44.
2007: Meissner Wassilios; Guigoni Celine; Cirilli Laetitia; Garret Maurice; Bioulac Bernard H; Gross Christian E; Bezard Erwan; Benazzouz Abdelhamid
Impact of chronic subthalamic high-frequency stimulation on metabolic basal ganglia activity: a 2-deoxyglucose uptake and cytochrome oxidase mRNA study in a macaque model of Parkinson's disease.
The European journal of neuroscience 2007;25(5):1492-500.
2007: Scheller Dieter; Chan Piu; Li Qin; Wu Tao; Zhang Renling; Guan Le; Ravenscroft Paula; Guigoni Celine; Crossman Alan R; Hill Michael; Bezard Erwan
Rotigotine treatment partially protects from MPTP toxicity in a progressive macaque model of Parkinson's disease.
Experimental neurology 2007;203(2):415-22.
2007: Pasquereau Benjamin; Nadjar Agnes; Arkadir David; Bezard Erwan; Goillandeau Michel; Bioulac Bernard; Gross Christian Eric; Boraud Thomas
Shaping of motor responses by incentive values through the basal ganglia.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2007;27(5):1176-83.
2006: Schapira Anthony H V; Bezard Erwan; Brotchie Jonathan; Calon Frédéric; Collingridge Graham L; Ferger Borris; Hengerer Bastian; Hirsch Etienne; Jenner Peter; Le Novère Nicolas; Obeso José A; Schwarzschild Michael A; Spampinato Umberto; Davidai Giora
Novel pharmacological targets for the treatment of Parkinson's disease.
Nature reviews. Drug discovery 2006;5(10):845-54.
2006: Li Qin; Zhao Deming; Bezard Erwan
Traditional Chinese medicine for Parkinson's disease: a review of Chinese literature.
Behavioural pharmacology 2006;17(5-6):403-10.
2006: Bezard Erwan
A call for clinically driven experimental design in assessing neuroprotection in experimental Parkinsonism.
Behavioural pharmacology 2006;17(5-6):379-82.
2006: Leblois Arthur; Meissner Wassilios; Bezard Erwan; Bioulac Bernard; Gross Christian E; Boraud Thomas
Temporal and spatial alterations in GPi neuronal encoding might contribute to slow down movement in Parkinsonian monkeys.
The European journal of neuroscience 2006;24(4):1201-8.
2006: Nadjar Agnes; Brotchie Jonathan M; Guigoni Celine; Li Qin; Zhou Shao-Bo; Wang Gui-Jie; Ravenscroft Paula; Georges François; Crossman Alan R; Bezard Erwan
Phenotype of striatofugal medium spiny neurons in parkinsonian and dyskinetic nonhuman primates: a call for a reappraisal of the functional organization of the basal ganglia.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2006;26(34):8653-61.
2006: Bezard Erwan; Gerlach Irene; Moratalla Rosario; Gross Christian E; Jork Reinhard
5-HT1A receptor agonist-mediated protection from MPTP toxicity in mouse and macaque models of Parkinson's disease.
Neurobiology of disease 2006;23(1):77-86.
2006: Meissner Wassilios; Ravenscroft Paula; Reese René; Harnack Daniel; Morgenstern Rudolf; Kupsch Andreas; Klitgaard Henrik; Bioulac Bernard; Gross Christian E; Bezard Erwan; Boraud Thomas
Increased slow oscillatory activity in substantia nigra pars reticulata triggers abnormal involuntary movements in the 6-OHDA-lesioned rat in the presence of excessive extracellular striatal dopamine.
Neurobiology of disease 2006;22(3):586-98.
2006: Bilbao Ainhoa; Cippitelli Andrea; Martín Ana Belén; Granado Noelia; Ortiz Oscar; Bezard Erwan; Chen Jiang-Fan; Navarro Miguel; Rodríguez de Fonseca Fernando; Moratalla R
Absence of quasi-morphine withdrawal syndrome in adenosine A2A receptor knockout mice.
Psychopharmacology 2006;185(2):160-8.
2006: Sokoloff P; Diaz J; Le Foll B; Guillin O; Leriche L; Bezard E; Gross C
The dopamine D3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders.
CNS & neurological disorders drug targets 2006;5(1):25-43.
2006: Kultima Kim; Scholz Birger; Alm Henrik; Sköld Karl; Svensson Marcus; Crossman Alan R; Bezard Erwan; Andrén Per E; Lönnstedt Ingrid
Normalization and expression changes in predefined sets of proteins using 2D gel electrophoresis: a proteomic study of L-DOPA induced dyskinesia in an animal model of Parkinson's disease using DIGE.
BMC bioinformatics 2006;7():475.
2005: Ghorayeb I; Bezard E; Fernagut P O; Bioulac B; Tison F
[Animal models of parkinsonism]
Revue neurologique 2005;161(10):907-15.
2005: Bassilana F; Mace N; Li Q; Stutzmann J M; Gross C E; Pradier L; Benavides J; Ménager J; Bezard E
Unraveling substantia nigra sequential gene expression in a progressive MPTP-lesioned macaque model of Parkinson's disease.
Neurobiology of disease 2005;20(1):93-103.
2005: Guo Shuhong; Bezard Erwan; Zhao Baolu
Protective effect of green tea polyphenols on the SH-SY5Y cells against 6-OHDA induced apoptosis through ROS-NO pathway.
Free radical biology & medicine 2005;39(5):682-95.
2005: Xie Yu-Xiang; Bezard Erwan; Zhao Bao-Lu
Investigating the receptor-independent neuroprotective mechanisms of nicotine in mitochondria.
The Journal of biological chemistry 2005;280(37):32405-12.
2005: Guigoni Céline; Dovero Sandra; Aubert Incarnation; Li Qin; Bioulac Bernard H; Bloch Bertrand; Gurevich Eugenia V; Gross Christian E; Bezard Erwan
Levodopa-induced dyskinesia in MPTP-treated macaques is not dependent on the extent and pattern of nigrostrial lesioning.
The European journal of neuroscience 2005;22(1):283-7.
2005: Guigoni C; Aubert I; Li Q; Gurevich V V; Benovic J L; Ferry S; Mach U; Stark H; Leriche L; Håkansson K; Bioulac Bernard H; Gross Christian E; Sokoloff Pierre; Fisone Gilberto; Gurevich E V; Bloch Bertrand; Bezard Erwan
Pathogenesis of levodopa-induced dyskinesia: focus on D1 and D3 dopamine receptors.
Parkinsonism & related disorders 2005;11 Suppl 1():S25-9.
2005: Hallett P J; Dunah A W; Ravenscroft P; Zhou S; Bezard E; Crossman A R; Brotchie J M; Standaert D G
Alterations of striatal NMDA receptor subunits associated with the development of dyskinesia in the MPTP-lesioned primate model of Parkinson's disease.
Neuropharmacology 2005;48(4):503-16.
2005: Bezard E; Gross C E; Qin Li; Gurevich V V; Benovic J L; Gurevich E V
L-DOPA reverses the MPTP-induced elevation of the arrestin2 and GRK6 expression and enhanced ERK activation in monkey brain.
Neurobiology of disease 2005;18(2):323-35.
2005: Guigoni Céline; Li Qin; Aubert Incarnation; Dovero Sandra; Bioulac Bernard H; Bloch Bertrand; Crossman Alan R; Gross Christian E; Bezard Erwan
Involvement of sensorimotor, limbic, and associative basal ganglia domains in L-3,4-dihydroxyphenylalanine-induced dyskinesia.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2005;25(8):2102-7.
2005: Aubert Incarnation; Guigoni Céline; Håkansson Kerstin; Li Qin; Dovero Sandra; Barthe Nicole; Bioulac Bernard H; Gross Christian E; Fisone Gilberto; Bloch Bertrand; Bezard Erwan
Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia.
Annals of neurology 2005;57(1):17-26.
2004: Pioli Elsa; Sohr Reinhard; Meissner Wassilios; Barthe Nicole; Gross Christian E; Bezard Erwan; Bioulac Bernard H
Partial bilateral mesencephalic lesions affect D1 but not D2 binding in both the striatum and cortex.
Neurochemistry international 2004;45(7):995-1004.
2004: Hsu Albert; Togasaki Daniel M; Bezard Erwan; Sokoloff Pierre; Langston J William; Di Monte Donato A; Quik Maryka
Effect of the D3 dopamine receptor partial agonist BP897 [N-[4-(4-(2-methoxyphenyl)piperazinyl)butyl]-2-naphthamide] on L-3,4-dihydroxyphenylalanine-induced dyskinesias and parkinsonism in squirrel monkeys.
The Journal of pharmacology and experimental therapeutics 2004;311(2):770-7.
2004: Pioli Elsa Y; Dovero Sandra; Bioulac Bernard H; Gross Christian E; Bezard Erwan
Asymmetrically lesioned mesencephalon in healthy rodents: call for caution.
Brain research 2004;1022(1-2):251-3.
2004: Diguet Elsa; Gross Christian E; Tison François; Bezard Erwan
Rise and fall of minocycline in neuroprotection: need to promote publication of negative results.
Experimental neurology 2004;189(1):1-4.
2004: Hill Michael P; Brotchie Jonathan M; Crossman Alan R; Bezard Erwan; Michel Anne; Grimée Renee; Klitgaard Henrik
Levetiracetam Interferes With the L-dopa priming process in MPTP-lesioned drug-naive marmosets.
Clinical neuropharmacology 2004;27(4):171-7.
2004: Hill Michael P; Ravenscroft Paula; Bezard Erwan; Crossman Alan R; Brotchie Jonathan M; Michel Anne; Grimée Renee; Klitgaard Henrik
Levetiracetam potentiates the antidyskinetic action of amantadine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned primate model of Parkinson's disease.
The Journal of pharmacology and experimental therapeutics 2004;310(1):386-94.
2004: Diguet Elsa; Fernagut Pierre-Olivier; Wei Xing; Du Yansheng; Rouland Richard; Gross Christian; Bezard Erwan; Tison François
Deleterious effects of minocycline in animal models of Parkinson's disease and Huntington's disease.
The European journal of neuroscience 2004;19(12):3266-76.
2004: Meissner Wassilios; Hill Michael P; Tison François; Gross Christian E; Bezard Erwan
Neuroprotective strategies for Parkinson's disease: conceptual limits of animal models and clinical trials.
Trends in pharmacological sciences 2004;25(5):249-53.
2004: Benazzouz Abdelhamid; Tai Chun Hwei; Meissner Wassilios; Bioulac Bernard; Bezard Erwan; Gross Christian
High-frequency stimulation of both zona incerta and subthalamic nucleus induces a similar normalization of basal ganglia metabolic activity in experimental parkinsonism.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2004;18(3):528-30.
2004: Meissner Wassilios; Harnack Daniel; Hoessle Nora; Bezard Erwan; Winter Christine; Morgenstern Rudolf; Kupsch Andreas
High frequency stimulation of the entopeduncular nucleus has no effect on striatal dopaminergic transmission.
Neurochemistry international 2004;44(4):281-6.
2004: Bezard Erwan; Hill Michael P; Crossman Alan R; Brotchie Jonathan M; Michel Anne; Grimée Renee; Klitgaard Henrik
Levetiracetam improves choreic levodopa-induced dyskinesia in the MPTP-treated macaque.
European journal of pharmacology 2004;485(1-3):159-64.
2004: Diguet E; Gross C E; Bezard E; Tison F; Stefanova N; Wenning G K
Neuroprotective agents for clinical trials in Parkinson's disease: a systematic assessment.
Neurology 2004;62(1):158; author reply 158-9.
2004: Guillin Oliver; Griffon Nathalie; Diaz Jorge; Le Foll Bernard; Bezard Erwan; Gross Christian; Lammers Chris; Stark Holger; Carroll Patrick; Schwartz Jean-Charles; Sokoloff Pierre
Brain-derived neurotrophic factor and the plasticity of the mesolimbic dopamine pathway.
International review of neurobiology 2004;59():425-44.
2003: Meissner Wassilios; Prunier Caroline; Guilloteau Denis; Chalon Sylvie; Gross Christian E; Bezard Erwan
Time-course of nigrostriatal degeneration in a progressive MPTP-lesioned macaque model of Parkinson's disease.
Molecular neurobiology 2003;28(3):209-18.
2003: Bezard Erwan; Dovero Sandra; Belin David; Duconger Sophie; Jackson-Lewis Vernice; Przedborski Serge; Piazza Pier Vincenzo; Gross Christian E; Jaber Mohamed
Enriched environment confers resistance to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and cocaine: involvement of dopamine transporter and trophic factors.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2003;23(35):10999-1007.
2003: Bezard Erwan; Baufreton Jerome; Owens Geraint; Crossman Alan R; Dudek Hank; Taupignon Anne; Brotchie Jonathan M
Sonic hedgehog is a neuromodulator in the adult subthalamic nucleus.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2003;17(15):2337-8.
2003: Hill Michael P; Bezard Erwan; McGuire Steven G; Crossman Alan R; Brotchie Jonathan M; Michel Ann; Grimée Renee; Klitgaard Henrik
Novel antiepileptic drug levetiracetam decreases dyskinesia elicited by L-dopa and ropinirole in the MPTP-lesioned marmoset.
Movement disorders : official journal of the Movement Disorder Society 2003;18(11):1301-5.
2003: Guillin Olivier; Griffon Nathalie; Bezard Erwan; Leriche Ludovic; Diaz Jorge; Gross Christian; Sokoloff Pierre
Brain-derived neurotrophic factor controls dopamine D3 receptor expression: therapeutic implications in Parkinson's disease.
European journal of pharmacology 2003;480(1-3):89-95.
2003: Tai Chun-Hwei; Boraud Thomas; Bezard Erwan; Bioulac Bernard; Gross Christian; Benazzouz Abdelhamid
Electrophysiological and metabolic evidence that high-frequency stimulation of the subthalamic nucleus bridles neuronal activity in the subthalamic nucleus and the substantia nigra reticulata.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2003;17(13):1820-30.
2003: Bezard Erwan
Neuroprotection for Parkinson's disease: a call for clinically driven experimental design.
Lancet neurology 2003;2(7):393.
2003: Meissner Wassilios; Dovero Sandra; Bioulac Bernard; Gross Christian E; Bezard Erwan
Compensatory regulation of striatal neuropeptide gene expression occurs before changes in metabolic activity of basal ganglia nuclei.
Neurobiology of disease 2003;13(1):46-54.
2003: Prunier Caroline; Payoux Pierre; Guilloteau Denis; Chalon Sylvie; Giraudeau Bruno; Majorel Cynthia; Tafani Mathieu; Bezard Erwan; Esquerré Jean-Paul; Baulieu Jean-Louis
Quantification of dopamine transporter by 123I-PE2I SPECT and the noninvasive Logan graphical method in Parkinson's disease.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(5):663-70.
2003: Marvanová Markéta; Ménager Jean; Bezard Erwan; Bontrop Ronald E; Pradier Laurent; Wong Garry
Microarray analysis of nonhuman primates: validation of experimental models in neurological disorders.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2003;17(8):929-31.
2003: Bezard Erwan; Gross Christian E; Brotchie Jonathan M
Presymptomatic compensation in Parkinson's disease is not dopamine-mediated.
Trends in neurosciences 2003;26(4):215-21.
2003: Pioli Elsa Y; Gross Christian E; Meissner Wassilios; Bioulac Bernard H; Bezard Erwan
The deafferented nonhuman primate is not a reliable model of intractable pain.
Neurological research 2003;25(2):127-9.
2003: Gross Christian E; Ravenscroft Paula; Dovero Sandra; Jaber Mohamed; Bioulac Bernard; Bezard Erwan
Pattern of levodopa-induced striatal changes is different in normal and MPTP-lesioned mice.
Journal of neurochemistry 2003;84(6):1246-55.
2002: Boraud Thomas; Bezard Erwan; Bioulac Bernard; Gross Christian E
From single extracellular unit recording in experimental and human Parkinsonism to the development of a functional concept of the role played by the basal ganglia in motor control.
Progress in neurobiology 2002;66(4):265-83.
2001: Bezard E; Dovero S; Prunier C; Ravenscroft P; Chalon S; Guilloteau D; Crossman A R; Bioulac B; Brotchie J M; Gross C E
Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2001;21(17):6853-61.
2001: Bezard E; Brotchie J M; Gross C E
Pathophysiology of levodopa-induced dyskinesia: potential for new therapies.
Nature reviews. Neuroscience 2001;2(8):577-88.
2001: Bezard E; Ravenscroft P; Gross C E; Crossman A R; Brotchie J M
Upregulation of striatal preproenkephalin gene expression occurs before the appearance of parkinsonian signs in 1-methyl-4-phenyl- 1,2,3,6-tetrahydropyridine monkeys.
Neurobiology of disease 2001;8(2):343-50.
2001: Bezard E; Crossman A R; Gross C E; Brotchie J M
Structures outside the basal ganglia may compensate for dopamine loss in the presymptomatic stages of Parkinson's disease.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2001;15(6):1092-4.
2001: Boraud T; Bezard E; Bioulac B; Gross C E
Dopamine agonist-induced dyskinesias are correlated to both firing pattern and frequency alterations of pallidal neurones in the MPTP-treated monkey.
Brain : a journal of neurology 2001;124(Pt 3):546-57.
2001: Bezard E; Boraud T; Chalon S; Brotchie J M; Guilloteau D; Gross C E
Pallidal border cells: an anatomical and electrophysiological study in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkey.
Neuroscience 2001;103(1):117-23.
2000: Bezard E; Dovero S; Imbert C; Boraud T; Gross C E
Spontaneous long-term compensatory dopaminergic sprouting in MPTP-treated mice.
Synapse (New York, N.Y.) 2000;38(3):363-8.
2000: Bezard E; Jaber M; Gonon F; Boireau A; Bloch B; Gross C E
Adaptive changes in the nigrostriatal pathway in response to increased 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration in the mouse.
The European journal of neuroscience 2000;12(8):2892-900.
2000: Ghorayeb I; Fernagut P O; Aubert I; Bezard E; Poewe W; Wenning G K; Tison F
Toward a primate model of L-dopa-unresponsive parkinsonism mimicking striatonigral degeneration.
Movement disorders : official journal of the Movement Disorder Society 2000;15(3):531-6.
2000: Boraud T; Bezard E; Bioulac B; Gross C E
Ratio of inhibited-to-activated pallidal neurons decreases dramatically during passive limb movement in the MPTP-treated monkey.
Journal of neurophysiology 2000;83(3):1760-3.
2000: Boraud T; Bezard E; Stutzmann J M; Bioulac B; Gross C E
Effects of riluzole on the electrophysiological activity of pallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkey.
Neuroscience letters 2000;281(2-3):75-8.
2000: Imbert C; Bezard E; Guitraud S; Boraud T; Gross C E
Comparison of eight clinical rating scales used for the assessment of MPTP-induced parkinsonism in the Macaque monkey.
Journal of neuroscience methods 2000;96(1):71-6.
1999: Gross C E; Boraud T; Guehl D; Bioulac B; Bezard E
From experimentation to the surgical treatment of Parkinson's disease: prelude or suite in basal ganglia research?
Progress in neurobiology 1999;59(5):509-32.
1999: Bezard E; Brefel C; Tison F; Peyro-Saint-Paul H; Ladure P; Rascol O; Gross C E
Effect of the alpha 2 adrenoreceptor antagonist, idazoxan, on motor disabilities in MPTP-treated monkey.
Progress in neuro-psychopharmacology & biological psychiatry 1999;23(7):1237-46.
1999: Guehl D; Bezard E; Dovero S; Boraud T; Bioulac B; Gross C
Trichloroethylene and parkinsonism: a human and experimental observation.
European journal of neurology : the official journal of the European Federation of Neurological Societies 1999;6(5):609-11.
1999: Bezard E; Boraud T; Nguyen J P; Velasco F; Keravel Y; Gross C
Cortical stimulation and epileptic seizure: a study of the potential risk in primates.
Neurosurgery 1999;45(2):346-50.
1999: Bezard E; Boraud T; Bioulac B; Gross C E
Involvement of the subthalamic nucleus in glutamatergic compensatory mechanisms.
The European journal of neuroscience 1999;11(6):2167-70.
1999: Bezard E; Gross C E; Fournier M C; Dovero S; Bloch B; Jaber M
Absence of MPTP-induced neuronal death in mice lacking the dopamine transporter.
Experimental neurology 1999;155(2):268-73.
1998: Bezard E; Stutzmann J M; Imbert C; Boraud T; Boireau A; Gross C E
Riluzole delayed appearance of parkinsonian motor abnormalities in a chronic MPTP monkey model.
European journal of pharmacology 1998;356(2-3):101-4.
1998: Bezard E; Gross C E
Compensatory mechanisms in experimental and human parkinsonism: towards a dynamic approach.
Progress in neurobiology 1998;55(2):93-116.
1998: Bezard E; Bioulac B; Gross C E
Glutamatergic compensatory mechanisms in experimental parkinsonism.
Progress in neuro-psychopharmacology & biological psychiatry 1998;22(4):609-23.
1998: Boraud T; Bezard E; Guehl D; Bioulac B; Gross C
Effects of L-DOPA on neuronal activity of the globus pallidus externalis (GPe) and globus pallidus internalis (GPi) in the MPTP-treated monkey.
Brain research 1998;787(1):157-60.
1998: Bezard E; Imbert C; Gross C E
Experimental models of Parkinson's disease: from the static to the dynamic.
Reviews in the neurosciences 1998;9(2):71-90.
1997: Bezard E; Dovero S; Bioulac B; Gross C
Effects of different schedules of MPTP administration on dopaminergic neurodegeneration in mice.
Experimental neurology 1997;148(1):288-92.
1997: Bezard E; Boraud T; Bioulac B; Gross C E
Compensatory effects of glutamatergic inputs to the substantia nigra pars compacta in experimental parkinsonism.
Neuroscience 1997;81(2):399-404.
1997: Bezard E; Dovero S; Bioulac B; Gross C E
Kinetics of nigral degeneration in a chronic model of MPTP-treated mice.
Neuroscience letters 1997;234(1):47-50.
1997: Bezard E; Imbert C; Deloire X; Bioulac B; Gross C E
A chronic MPTP model reproducing the slow evolution of Parkinson's disease: evolution of motor symptoms in the monkey.
Brain research 1997;766(1-2):107-12.
1997: Beurrier C; Bezard E; Bioulac B; Gross C
Subthalamic stimulation elicits hemiballismus in normal monkey.
Neuroreport 1997;8(7):1625-9.
1997: Bezard E; Boraud T; Bioulac B; Gross C E
Presymptomatic revelation of experimental parkinsonism.
Neuroreport 1997;8(2):435-8.
1996: Boraud T; Bezard E; Bioulac B; Gross C
High frequency stimulation of the internal Globus Pallidus (GPi) simultaneously improves parkinsonian symptoms and reduces the firing frequency of GPi neurons in the MPTP-treated monkey.
Neuroscience letters 1996;215(1):17-20.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Erwan Bezard

Research Profile (preview)

Disorders

Chemicals & Drugs

Living Beings

Anatomy

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Erwan Bezard (preview)

All Publications